xzorro123

Bristol-Myers, ImClone, Genentech Release Promising Data at ASCO

It is a pity that not also is commented on the 3 encouraging clinical trials of Genvec for :
1. pancreatic tumor- Phase 3
2. esophageal tumor- Phase 2
3. Head and neck tumor: Phase 1

Genentech is a MegaCap company and GNVC is a SmallCap company. Hence, the effect on GNVC s.p. is most likely more significant.

DYODD